The Weekly Roundup: September 9-13

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Oral Zasocitinib Demonstrates Safety and Efficacy in Moderate to Severe Plaque Psoriasis

The oral TYK2 inhibitor demonstrated biologic-level efficacy.

Availability of Apremilast in US for Pediatric Patients Opens Avenues for Expanded Treatment Options and Oral Therapy

Dermatology Times spoke with Leah Howard, JD, of the NPF, and Trisha, the mother of a young girl with psoriasis, to discuss Otezla's implications in the therapeutic landscape.

Publishing Excellence Runs More Than Skin Deep

Reflecting on the past 2 decades of healthcare as MJH Life Sciences® wraps up its 25-year anniversary celebration.

Isotretinoin’s Role in Rosacea Management

A recent review found the LDI shows significant symptom improvement, but needs further study for long-term maintenance.

Study Compares Dose Escalation with Biologics in Psoriasis

The study reported that UST leads in dose escalation frequency, but also had lower discontinuation rates when compared to ADA and ETN.

Tackle Sports Dermatoses

It is important that dermatology providers can easily recognize and treat communicable sports dermatoses, writes Shanna Miranti, MMS, PA-C.

Preclinical Medical Students Perform Similarly in Evaluating, Diagnosing Dermatological Diseases in Varying Skin Types

Researchers reported that second-year students were more likely to identify dermatological conditions, particularly in White patients.

CG and Minoxidil Combination Therapy Shows Promise for AA

A recent review found glycyrrhizin improves minoxidil's efficacy in treating AA, showing reduced severity and improved hair density.

Nearly half of FDA-authorized AI tools may be ineffective

Researchers stated the lack of reported clinical validation data raises concerns about their effectiveness and safety.

Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors

The review assessed infections, gastrointestinal AEs, blood and lymphatic disorders, and nervous system and musculoskeletal/connective tissue disorders.

Research Highlights Disparities in Melanoma Knowledge and Care

Swiss researchers found significant gender differences in melanoma care, including variations in information preferences and treatment decision-making.

Phase 3 LIBERTY-CUPID Study C Trial for Dupilumab Meets Primary, Secondary Endpoints for Chronic Spontaneous Urticaria

These positive data will support US regulatory submission by end of 2024.

Sanofi Reports High Efficacy in Dupilumab for BP

New study results show promise in dupilumab for bullous pemphigoid, with 59% of patients avoiding disease relapse.

What Conferences Are You Planning to Attend in Quarter 4 of 2024?

Ahead of the next 3 months of the year, Dermatology Times wants to know what conferences and meetings you plan to attend between October and December. Share your thoughts with us by September 25.

Understanding and Treating Pseudo Acne Fulminans

Shanna Miranti, MMS, PA-C, reviews 2 patient cases of pseudo acne fulminans, offering perspectives on treatment and management strategies.

Self-Stigma's Role in Chronic Skin Conditions

A recent reviewed showed that self-stigma in patients with skin disease is influenced by body image issues and social support.

SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis

The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.

The Impact of Tropical Weather on Patients with Atopic Dermatitis in Hurricane-Prone Areas

Hurricane flooding results in a surge of mold, mildew, and allergens, which can trigger or exacerbate AD symptoms.

BD2-Selective BET Inhibitor VYN202 Demonstrates Positive Safety and Tolerability in Phase 1a Trial

The subsequent MAD portion of the study has commenced dosing. Results are anticipated in Q4.

Finger-to-Palm Distance Among Potential Indicators of Skin Thickening, Early-Onset Systemic Sclerosis

Researchers reported several factors and indicators that may predict early-stage systemic sclerosis among patients in Japan.

Comparing Devices to Assess Facial Pigmentary and Inflammatory Conditions

Precision measurements are necessary to improve the current therapeutic armamentarium in pigmentary disorders.

Definitions and Diagnostic Criteria of Generalized Pustular Psoriasis Require Continuity, Accuracy, Researchers Report

Researchers authored a manuscript detailing considerations for GPP diagnosis, definitions, and management.

Unmasking Botulinum Toxin Myths

Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.

April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report

Armstrong shared insights on the recently released NPF psoriasis health indicator report including pearls on national health data and unmet needs in public health campaigns.